Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

A. Chiang · SciRah

Researcher profile · Semantic Scholar

A. Chiang

Share profile

A. Chiang — researcher profile on SciRah

h-index: 25
Works: 107
Citations: 5,918

Most-cited papers

A Phase II trial of pembrolizumab for patients with melanoma or non-small cell lung cancer and untreated brain metastases
S. Goldberg, S. Gettinger, A. Mahajan, A. Chiang +17 more
2016The Lancet Oncology899 citations Open access
Semantic Scholar
Impaired HLA Class I Antigen Processing and Presentation as a Mechanism of Acquired Resistance to Immune Checkpoint Inhibitors in Lung Cancer
S. Gettinger, Jungmin Choi, K. Hastings, A. Truini +22 more
2017Cancer Discovery698 citations Open access
Semantic Scholar
Pembrolizumab for management of patients with NSCLC and brain metastases: long-term results and biomarker analysis from a non-randomized, open-label, phase 2 trial
S. Goldberg, K. Schalper, S. Gettinger, A. Mahajan +20 more
2020The Lancet Oncology442 citations Open access
Semantic Scholar
Small Cell Lung Cancer, Version 2.2022, NCCN Clinical Practice Guidelines in Oncology
A. Ganti, B. Loo, M. Bassetti, C. Blakely +30 more
2021The Journal of the National Comprehensive Cancer Network423 citations Open access
Semantic Scholar
Association of Broad-Based Genomic Sequencing With Survival Among Patients With Advanced Non–Small Cell Lung Cancer in the Community Oncology Setting
C. Presley, Dai-Wei Tang, P. Soulos, A. Chiang +9 more
2018Journal of the American Medical Association (JAMA)130 citations Open access
Semantic Scholar
Clinical Features and Management of Acquired Resistance to PD-1 Axis Inhibitors in 26 Patients With Advanced Non–Small Cell Lung Cancer
S. Gettinger, A. Wurtz, S. Goldberg, D. Rimm +8 more
2018Journal of Thoracic Oncology120 citations Open access
Semantic Scholar
Randomized Phase II Study of Paclitaxel plus Alisertib versus Paclitaxel plus Placebo as Second-Line Therapy for Small-Cell Lung Cancer: Primary and Correlative Biomarker Analyses.
T. Owonikoko, H. Niu, K. Nackaerts, T. Csőszi +32 more
2020Journal of Thoracic Oncology119 citations Open access
Semantic Scholar
Speed of Adoption of Immune Checkpoint Inhibitors of Programmed Cell Death 1 Protein and Comparison of Patient Ages in Clinical Practice vs Pivotal Clinical Trials
J. M. O'Connor, K. Fessele, J. Steiner, Kathi Seidl-Rathkopf +9 more
2018JAMA Oncology105 citations Open access
Semantic Scholar
Immune-related sarcoidosis observed in combination ipilimumab and nivolumab therapy
Kathleen C. Suozzi, M. Stahl, C. Ko, A. Chiang +3 more
2016JAAD Case Reports93 citations Open access
Semantic Scholar
Patient-Reported Outcome Performance Measures in Oncology
E. Basch, C. Snyder, K. McNiff, Rebecca Brown +9 more
2014Journal of Oncology Practice90 citations Open access
Semantic Scholar
Survival Rates after Thermal Ablation versus Stereotactic Radiation Therapy for Stage 1 Non-Small Cell Lung Cancer: A National Cancer Database Study.
J. Uhlig, J. Ludwig, S. Goldberg, A. Chiang +2 more
2018Radiology79 citations
Semantic Scholar
Possible Interaction of Anti–PD-1 Therapy with the Effects of Radiosurgery on Brain Metastases
A. Alomari, J. Cohen, A. Vortmeyer, A. Chiang +4 more
2016Cancer immunology research51 citations Open access
Semantic Scholar
Clinical activity, safety and predictive biomarkers results from a phase Ia atezolizumab (atezo) trial in extensive-stage small cell lung cancer (ES-SCLC)
L. Sequist, A. Chiang, J. Gilbert, M. Gordon +10 more
201646 citations Open access
Semantic Scholar
Frontline immunotherapy for NSCLC — the tale of the tail
A. Chiang, R. Herbst
2020Nature Reviews Clinical Oncology44 citations
Semantic Scholar
Comparison of Survival Rates After a Combination of Local Treatment and Systemic Therapy vs Systemic Therapy Alone for Treatment of Stage IV Non–Small Cell Lung Cancer
J. Uhlig, M. D. Case, J. Blasberg, D. Boffa +3 more
2019JAMA Network Open43 citations Open access
Semantic Scholar
Durability of brain metastasis response and overall survival in patients with non-small cell lung cancer (NSCLC) treated with pembrolizumab.
S. Goldberg, S. Gettinger, A. Mahajan, R. Herbst +9 more
201842 citations
Semantic Scholar
Activity and safety of pembrolizumab in patients with metastatic non-small cell lung cancer with untreated brain metastases.
S. Goldberg, S. Gettinger, A. Mahajan, R. Herbst +12 more
201540 citations
Semantic Scholar
Qualitative analysis of practicing oncologists' attitudes and experiences regarding collection of patient-reported outcomes.
R. Jagsi, A. Chiang, B. Polite, B. C. Medeiros +4 more
2013Journal of Oncology Practice32 citations
Semantic Scholar
Incorporating patient-reported outcomes to improve emotional distress screening and assessment in an ambulatory oncology clinic.
A. Chiang, Stephanie Buia Amport, Diane Corjulo, K. L. Harvey +1 more
2015Journal of Oncology Practice30 citations
Semantic Scholar
Management of Small Cell Lung Cancer: Progress and Updates
M. Altan, A. Chiang
2015Cancer Journal29 citations
Semantic Scholar
EGFR mutation testing and treatment decisions in patients progressing on first- or second-generation epidermal growth factor receptor tyrosine kinase inhibitors
A. Chiang, Ancilla W. Fernandes, M. Pavilack, Jennifer W. Wu +4 more
2020BMC Cancer28 citations Open access
Semantic Scholar
Clinical Activity and Safety of Atezolizumab in a Phase 1 Study of Patients With Relapsed/Refractory Small-Cell Lung Cancer.
A. Chiang, Lecia Van Dam Sequist, J. Gilbert, P. Conkling +9 more
2020Clinical Lung Cancer25 citations Open access
Semantic Scholar
Small Cell Lung Cancer, Version 2.2022
A. Ganti, B. Loo, M. Bassetti, C. Blakely +30 more
202120 citations
Semantic Scholar
Final results of phase Ib of tarextumab (TRXT, OMP-59R5, anti-Notch2/3) in combination with etoposide and platinum (EP) in patients (pts) with untreated extensive-stage small-cell lung cancer (ED-SCLC).
M. Pietanza, A. Spira, R. Jotte, S. Gadgeel +11 more
201520 citations
Semantic Scholar
First-in-human study of ABBV-011, a seizure-related homolog protein 6 (SEZ6)–targeting antibody-drug conjugate, in patients with small cell lung cancer.
D. Morgensztern, N. Ready, M. Johnson, A. Dowlati +16 more
2023Journal of Clinical Oncology18 citations Open access
Semantic Scholar
1530PDResults of a randomized, placebo-controlled, phase 2 study of tarextumab (TRXT, anti-Notch2/3) in combination with etoposide and platinum (EP) in patients (pts) with untreated extensive-stage small-cell lung cancer (ED-SCLC)
D. Daniel, C. Rudin, L. Hart, D. Spigel +13 more
201717 citations Open access
Semantic Scholar
MA15.11 Real World Biomarker Testing and Treatment Patterns in Patients with Advanced NSCLC Receiving EGFR-TKIs
A. Chiang, Ancilla W. Fernandes, M. Pavilack, J. Wu +4 more
2018Journal of Thoracic Oncology15 citations Open access
Semantic Scholar
Performance Measures Based on How Adults With Cancer Feel and Function: Stakeholder Recommendations and Feasibility Testing in Six Cancer Centers.
A. Stover, B. Urick, A. Deal, R. Teal +24 more
2020JCO Oncology Practice11 citations Open access
Semantic Scholar
Disparities in next generation sequencing in a population-based community cohort of patients with advanced non-small cell lung cancer.
C. Presley, P. Soulos, A. Chiang, J. Longtine +7 more
201710 citations
Semantic Scholar
Perspectives on the Use of Clinical Pathways in Oncology Care.
A. Chiang, Peter G. Ellis, R. Zon
2017American Society of Clinical Oncology educational book. American Society of Clinical Oncology. Annual Meeting10 citations
Semantic Scholar
Establishing a Core Set of Performance Measures to Improve Value in Cancer Care: ASCO Consensus Conference Recommendation Report.
M. Neuss, G. Rocque, D. Zuckerman, A. Chiang +4 more
2017Journal of Oncology Practice9 citations Open access
Semantic Scholar
Pneumonitis in non-small cell lung cancer (NSCLC) patients treated with programmed death 1 (PD1) axis inhibitors.
S. Gettinger, Xu-Chen Zhang, Robert J. Homer, J. Possick +5 more
20169 citations
Semantic Scholar
Phase I study of AMG 757, a half-life extended bispecific T-cell engager (HLE BiTE immune therapy) targeting DLL3, in patients with small cell lung cancer (SCLC).
T. Owonikoko, H. Borghaei, S. Champiat, L. Paz-Ares +16 more
20208 citations
Semantic Scholar
Measuring the Impact of Academic Cancer Network Development on Clinical Integration, Quality of Care, and Patient Satisfaction.
A. Chiang, J. Lake, N. Sinanis, D. Brandt +18 more
2018Journal of Oncology Practice8 citations Open access
Semantic Scholar
A Phase II trial of pembrolizumab for patients with melanoma or non-small cell lung cancer and untreated brain metastases
S. Goldberg, S. Gettinger, A. Mahajan, A. Chiang +20 more
20178 citations
Semantic Scholar
KeyVibe-008: Randomized, phase 3 study of first-line vibostolimab plus pembrolizumab plus etoposide/platinum versus atezolizumab plus EP in extensive-stage small cell lung cancer.
J. Sands, M. Reck, A. Navarro, A. Chiang +10 more
2022Journal of Clinical Oncology7 citations
Semantic Scholar
What Is New in Small Cell Lung Cancer.
R. Matera, A. Chiang
2023Hematology/Oncology Clinics of North America6 citations
Semantic Scholar
Updated results of phase 1b study of tarextumab (TRXT, anti-Notch2/3) in combination with etoposide and platinum (EP) in patients (pts) with untreated extensive-stage small-cell lung cancer (ED-SCLC).
A. Chiang, C. Rudin, A. Spira, R. Jotte +11 more
20166 citations
Semantic Scholar
Objective measurement and significance of PD-L1, B7-H3, B7-H4 and TILs in small cell lung cancer (SCLC).
K. Schalper, D. Carvajal-Hausdorf, J. McLaughlin, M. Altan +10 more
20166 citations
Semantic Scholar
ASCO PRO workgroup update: Patient-reported outcome measures as a quality indicator.
A. Stover, A. Chiang, E. Basch
2016Journal of Clinical Oncology6 citations
Semantic Scholar
145MO Updated survival, efficacy and safety of adjuvant (adj) atezolizumab (atezo) after neoadjuvant (neoadj) atezo in the phase II LCMC3 study
D. Carbone, S. Waqar, J. Chaft, M. Kris +13 more
2023Journal of Thoracic Oncology5 citations Open access
Semantic Scholar
Oral Chemotherapy Metric Performance in Quality Oncology Practice Initiative Practices: Updated Trends and Analysis.
V. Blinder, E. Garrett-Mayer, P. Jacobsen, Mary May Priscilla Kozlik +6 more
2022The Journal of the National Comprehensive Cancer Network5 citations Open access
Semantic Scholar
OA11.03 A Phase 1 Study of AMG 757, Half-Life Extended Bispecific T-Cell Engager (BiTE®)Immune Therapy Against DLL3, in SCLC
T. Owonikoko, M. Boyer, M. Johnson, R. Govindan +21 more
20215 citations Open access
Semantic Scholar
359 AMG 757, a half-life extended bispecific T-cell engager (BiTE®) immune therapy against DLL3 in SCLC: phase 1 interim results
H. Borghaei, M. Boyer, M. Johnson, R. Govindan +18 more
20205 citations Open access
Semantic Scholar
Disparities in broad-based genomic sequencing for patients with advanced non-small cell lung cancer.
Fauzia Riaz, C. Presley, A. Chiang, J. Longtine +8 more
2019Journal of Geriatric Oncology5 citations
Semantic Scholar
Final Results of a Phase I Prospective Trial Evaluating the Combination of Stereotactic Body Radiation Therapy (SBRT) with Concurrent Pembrolizumab in Patients with Metastatic Non-Small Cell Lung Cancer (NSCLC) or Melanoma
A. Campbell, R. Herbst, S. Gettinger, S. Goldberg +7 more
2018International Journal of Radiation Oncology, Biology, Physics5 citations Open access
Semantic Scholar
Why the Quality Oncology Practice Initiative Matters: It's Not Just About Cost.
A. Chiang
2016American Society of Clinical Oncology educational book. American Society of Clinical Oncology. Annual Meeting5 citations
Semantic Scholar
Characterization of aggressive interventions within 30 days of death in lung cancer patients at Smilow Cancer Hospital (SCH).
Bing-Nan Zhang, K. Adelson, Salimah Velji, J. Rimar +4 more
2014Journal of Clinical Oncology5 citations
Semantic Scholar
COVID-19 and Cancer Center Operations: Lessons Learned From the NCCN Best Practices Committee.
Jessica Sugalski, T. Franco, L. Shulman, Elizabeth Souza +5 more
2022The Journal of the National Comprehensive Cancer Network4 citations
Semantic Scholar
ASCO Quality Training Program: A Five-Year Review.
M. Keng, Doris Quinn, Gene Cunningham, John W. Bingham +9 more
2020JCO Oncology Practice4 citations
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

S. Gettinger×14
Invite
S. Gettinger — researcher profile on SciRah
R. Herbst×14
Invite
R. Herbst — researcher profile on SciRah
S. Goldberg×11
Invite
S. Goldberg — researcher profile on SciRah
H. Kluger×7
Invite
H. Kluger — researcher profile on SciRah

×7

Invite

A. Dowlati — researcher profile on SciRah

Invite

K. Adelson — researcher profile on SciRah

Invite

A. Mahajan — researcher profile on SciRah

Lucia B. Jilaveanu×5

Invite

Lucia B. Jilaveanu — researcher profile on SciRah

Invite

E. Rowen — researcher profile on SciRah

Invite

H. Gerrish — researcher profile on SciRah

Invite

V. Chiang — researcher profile on SciRah

Invite

K. Schalper — researcher profile on SciRah